欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Neuronal Signaling  /  NMDAR  /  CIQ

CAS No.: 486427-17-2

CIQ Catalog No. CSN18296

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT01580293Hemophilia APhase 2 Phase 3Active, not recruitingJanuary 10, 2020-
    NCT03370913Hemophilia APhase 3RecruitingSeptember 2023-
    NCT02435173Common Variable Immunodeficien... more >>cy (CVID) More Specifically Activated PI3Kdelta Syndrome (APDS) p110delta-activating Mutation Causing Senescent T Cells Lymphadenopathy and Immunodeficiency (PASLI) Collapse <<Phase 2 Phase 3RecruitingFebruary 6, 2020United States, Maryland ... more >> National Institute of Health NIH Recruiting Bethesda, Maryland, United States, 20814 Contact: Sharon Webster    301-496-2771    Sharon.webster@nih.gov    Czechia Novartis Investigative Site Recruiting Prague 5, Czechia, 150 00 Ireland Novartis Investigative Site Recruiting Dublin, Ireland Italy Novartis Investigative Site Recruiting Brescia, Italy, 25123 Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3000 CA Russian Federation Novartis Investigative Site Recruiting Moscow, Russian Federation, 117198 United Kingdom Novartis Investigative Site Recruiting Belfast, United Kingdom, BT9 7AB Novartis Investigative Site Recruiting London, United Kingdom, NW3 2PF Collapse <<
  • 更多

实验方案

技术信息

CAS号 486427-17-2 储存条件
分子式 C26H26ClNO5 运输 蓝冰
分子量 467.94 别名

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们